Novartis Ag (NVS) Capital Expenditures (QoQ) (2009 - 2026)
| Date | Value |
| Mar 31, 2026 |
43.19% |
| Dec 31, 2025 |
-72.03% |
| Sep 30, 2025 |
-6.95% |
| Jun 30, 2025 |
-30.31% |
| Mar 31, 2025 |
54.48% |
| Dec 31, 2024 |
-73.83% |
| Sep 30, 2024 |
-23.46% |
| Jun 30, 2024 |
-14.54% |
| Mar 31, 2024 |
44.09% |
| Dec 31, 2023 |
-55.56% |
| Sep 30, 2023 |
-16.00% |
| Jun 30, 2023 |
-33.93% |
| Mar 31, 2023 |
45.10% |
| Dec 31, 2022 |
-38.46% |
| Sep 30, 2022 |
14.01% |
| Jun 30, 2022 |
0.00% |
| Mar 31, 2022 |
44.13% |
| Dec 31, 2021 |
-31.05% |
| Sep 30, 2021 |
-9.35% |
| Jun 30, 2021 |
-30.49% |
| Mar 31, 2021 |
52.78% |
| Dec 31, 2020 |
-86.74% |
| Sep 30, 2020 |
-17.23% |
| Jun 30, 2020 |
-0.42% |
| Mar 31, 2020 |
48.59% |
| Dec 31, 2019 |
-29.13% |
| Sep 30, 2019 |
-27.96% |
| Jun 30, 2019 |
1.06% |
| Mar 31, 2019 |
36.49% |
| Dec 31, 2018 |
-50.51% |
| Sep 30, 2018 |
-14.79% |
| Jun 30, 2018 |
0.39% |
| Mar 31, 2018 |
59.56% |
| Dec 31, 2017 |
-67.02% |
| Sep 30, 2017 |
-15.06% |
| Jun 30, 2017 |
3.49% |
| Mar 31, 2017 |
41.30% |
| Dec 31, 2016 |
-32.28% |
| Sep 30, 2016 |
1.12% |
| Jun 30, 2016 |
-16.36% |
| Mar 31, 2016 |
48.87% |
| Dec 31, 2015 |
-30.05% |
| Sep 30, 2015 |
-102,296,719.79% |
| Jun 30, 2015 |
-20.68% |
| Mar 31, 2015 |
43.49% |
| Dec 31, 2014 |
-24.25% |
| Sep 30, 2014 |
-3.73% |
| Jun 30, 2014 |
-33.61% |
| Sep 30, 2013 |
-19.91% |
| Jun 30, 2013 |
-27.36% |
| Sep 30, 2012 |
-9.60% |
| Jun 30, 2012 |
-46.60% |
| Mar 31, 2012 |
47.52% |
| Dec 31, 2011 |
-53.92% |
| Sep 30, 2011 |
-12.58% |
| Jun 30, 2011 |
-8.11% |
| Mar 31, 2011 |
37.74% |
| Dec 31, 2010 |
-94.51% |
| Sep 30, 2010 |
2.54% |
| Jun 30, 2010 |
-16.78% |
| Mar 31, 2010 |
50.89% |
| Dec 31, 2009 |
-49.16% |
| Sep 30, 2009 |
14.43% |
| Jun 30, 2009 |
-31.79% |